Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors

被引：0
|
作者：
Eriksson, B. [1 ]
Sundin, A. [2 ]
Wassberg, C. [2 ]
Skogseid, B. [1 ]
Antonodimitrakis, P. [1 ]
机构：
[1] Dept Med Sci, Uppsala, Sweden
[2] Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2014年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FP7.1
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [1] Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
    Antonodimitrakis, Pantelis Clewemar
    Sundin, Anders
    Wassberg, Cecilia
    Granberg, Dan
    Skogseid, Britt
    Eriksson, Barbro
    NEUROENDOCRINOLOGY, 2016, 103 (3-4) : 345 - 353
  • [2] Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors Case series
    Mueller, Christian
    Kreissl, Michael C.
    Klose, Silke
    Krause, Andreas
    Keitel, Verena
    Venerito, Marino
    MEDICINE, 2022, 101 (04) : E28610
  • [3] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Harald Lahner
    Annie Mathew
    Anna Lisa Klocker
    Nicole Unger
    Jens Theysohn
    Jan Rekowski
    Karl-Heinz Jöckel
    Sarah Theurer
    Kurt Werner Schmid
    Ken Herrmann
    Dagmar Führer
    Endocrine, 2022, 75 : 293 - 302
  • [4] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Lahner, Harald
    Mathew, Annie
    Klocker, Anna Lisa
    Unger, Nicole
    Theysohn, Jens
    Rekowski, Jan
    Joeckel, Karl-Heinz
    Theurer, Sarah
    Schmid, Kurt Werner
    Herrmann, Ken
    Fuehrer, Dagmar
    ENDOCRINE, 2022, 75 (01) : 293 - 302
  • [5] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    M A Gonzalez
    S Biswas
    L Clifton
    P G Corrie
    British Journal of Cancer, 2003, 89 : 455 - 456
  • [6] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    Gonzalez, MA
    Biswas, S
    Clifton, L
    Corrie, PG
    BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 455 - 456
  • [7] Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
    N C Turner
    S J Strauss
    D Sarker
    R Gillmore
    A Kirkwood
    A Hackshaw
    A Papadopoulou
    J Bell
    I Kayani
    C Toumpanakis
    F Grillo
    A Mayer
    D Hochhauser
    R H Begent
    M E Caplin
    T Meyer
    British Journal of Cancer, 2010, 102 : 1106 - 1112
  • [8] Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
    Turner, N. C.
    Strauss, S. J.
    Sarker, D.
    Gillmore, R.
    Kirkwood, A.
    Hackshaw, A.
    Papadopoulou, A.
    Bell, J.
    Kayani, I.
    Toumpanakis, C.
    Grillo, F.
    Mayer, A.
    Hochhauser, D.
    Begent, R. H.
    Caplin, M. E.
    Meyer, T.
    BRITISH JOURNAL OF CANCER, 2010, 102 (07) : 1106 - 1112
  • [9] Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors
    Rogers, Jane E.
    Lam, Michael
    Halperin, Daniel M.
    Dagohoy, Cecile G.
    Yao, James C.
    Dasari, Arvind
    NEUROENDOCRINOLOGY, 2022, 112 (01) : 34 - 42
  • [10] Outcomes With 5-Fluorouracil, Doxorubicin, and Streptozocin (FAS) and Subsequent Therapies in Patients With Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs)
    Lam, Michael
    Rogers, Jane
    Halperin, Daniel
    Dagohoy, Cecile
    Yao, James
    Dasari, Arvind
    PANCREAS, 2019, 48 (03) : 443 - 444
12345